Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Raj Chovatiya
Observed names:
Chovatiya, Raj,
R. Chovatiya
Institution:
Rosalind Franklin University of Medicine and Science
Observed institutions:
Northwestern University,
Rosalind Franklin University of Medicine and Science,
George Washington University
ORCID:
0000-0001-6510-399X
Observed ORCID:
0000-0001-6510-399X
OpenAlex ID:
A5028960889
0206 Impact of seborrheic dermatitis on quality of life: a systematic review and meta analysis
2025
·
J. Chen
, C. Li
, et al.
·
Dermatology Practical & Conceptual
·
2
PDF
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years
2026
·
Eric Simpson
, Tilo Biedermann
, et al.
·
Journal of Dermatological Treatment
·
1
PDF
0299 Prevalence and severity of mental health symptoms with seborrheic dermatitis: A systematic review and meta-analysis
2025
·
J. Chen
, C. Li
, et al.
·
Journal of Investigative Dermatology
·
1
PDF
Self-reported disease severity and treatment experience among individuals reporting healthcare professional diagnosed Chronic Hand Eczema: Findings from cross-sectional CHECK-US study
2026
·
Adis journals on behalf of:
, Raj Chovatiya
, et al.
·
Figshare
INDIVIDUAL ARTICLE: Tildrakizumab for Real-World Psoriasis Care: Clinical Lessons From Medically Complex and Underserved Patient Populations
2026
·
Julian A. Cortes
, Boni Elewski
, et al.
·
Journal of Drugs in Dermatology
0465 Roflumilast foam 0.3% in patients with seborrheic dermatitis and prior inadequate response, intolerance, and/or contraindications to topical antifungals and/or topical corticosteroids
2026
·
R. Chovatiya
, E. Domingues
, et al.
·
Journal of Investigative Dermatology
LB1150 A novel oral pyruvate kinase M2 (PKM2) modulator for atopic dermatitis (SYX-5219) demonstrates favorable safety, pharmacokinetics, target engagement and evidence of type 2 immunomodulation: results from a first-in-human Phase 1a study
2026
·
A. Irvine
, R. Chovatiya
, et al.
·
Journal of Investigative Dermatology
PDF
The role of TSLP in atopic dermatitis: a scoping review
2026
·
Rivera, Patricia
, Bashir, Neha
, et al.
The Role of IL-33 in Atopic Dermatitis: A Scoping Review
2026
·
Bashir, Neha
, Yoon, Elaine
, et al.
The role of TL1A in atopic dermatitis: a scoping review
2026
·
Yoon, Elaine
, Duong, Kelly
, et al.
0201 Prevalence and association of cardiovascular comorbidities in prurigo nodularis: A systematic review and meta-analysis
2025
·
N. Chalupczak
, C. Li
, et al.
·
Journal of Investigative Dermatology
PDF
LB1144 Treatment-free disease control after tralokinumab in patients with moderate-to-severe atopic dermatitis
2025
·
A. Blauvelt
, T. Bhutani
, et al.
·
Journal of Investigative Dermatology
0296 Paving a path for standardized diagnosis: A systematic review and analysis of seborrheic dermatitis diagnostic criteria
2025
·
C. Li
, J. Chen
, et al.
·
Journal of Investigative Dermatology
PDF
0297 Global prevalence of atopic comorbidities in prurigo nodularis: A systematic review and meta-analysis
2025
·
N. Chalupczak
, C. Li
, et al.
·
Journal of Investigative Dermatology
PDF
Achievement of Itch-free State and Sleep Improvement With Tapinarof in Two Pivotal Atopic Dermatitis Trials
2024
·
E. Simpson
, D. Siri
, et al.
·
Annals of Allergy Asthma & Immunology
324 Describing atopic dermatitis in the real world: A retrospective health system analysis
2024
·
M. Polaskey
, R. Chovatiya
·
Journal of Investigative Dermatology
PDF
161 Prevalence of seborrheic dermatitis: A systematic review and meta-analysis
2024
·
M. Polaskey
, C. Chang
, et al.
·
Journal of Investigative Dermatology
PDF
693 Social media as an educational platform for seborrheic dermatitis
2023
·
S. Fakhraie
, R. Chovatiya
·
Journal of Investigative Dermatology
PDF
Show more works
View as search
Works count:
18
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type